Wealth Dimensions Group Ltd. increased its stake in shares of Dimensional Emerging Core Equity Market ETF (NYSEARCA:DFAE – Free Report) by 16.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 252,425 shares of the company’s stock after purchasing an […]
Wealth Dimensions Group Ltd. cut its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 14.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,982 shares of the company’s stock after selling 512 shares during the quarter. Wealth Dimensions Group […]
Wealth Dimensions Group Ltd. trimmed its stake in shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 37.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,196 shares of the company’s stock after selling 1,931 shares during the quarter. Wealth Dimensions […]
Wealth Dimensions Group Ltd. trimmed its position in shares of iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 4.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 9,526 shares of the exchange traded fund’s stock after selling 465 shares during the period. iShares Russell 1000 Growth ETF accounts for approximately […]
Wealth Dimensions Group Ltd. trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 4.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,873 shares of the company’s stock after selling 709 shares during the quarter. Wealth Dimensions […]